Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 2, 2023
Network-Guided Multiomic Mapping of Aortic Valve Calcification
Mark C Blaser, Simon Kraler, Thomas F Lüscher, et al.
Journal of Cardiovascular Pharmacology
|
January 23, 2025
Colchicine in Coronary Artery Disease: Where Do We Stand?
Aldo Bonaventura, Nicola Potere, Luca Liberale, et al.
Frontiers in Cardiovascular Medicine
|
August 9, 2023
Editorial: Implications of lipids and modified lipoproteins in atherogenesis: from mechanisms towards novel diagnostic and therapeutic targets
Simon Kraler, Tatsuya Sawamura, Grace Yen-Shin Harn, et al.
European Heart Journal
|
December 1, 2021
Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy
Simon Kraler, Mark C Blaser, Elena Aikawa, et al.
Current Atherosclerosis Reports
|
March 22, 2025
Inflammation-Driven Plaque Erosion in Atherosclerosis: A Focus on Complement System Pathways
Davide Ramoni, Federico Carbone, Simon Kraler, et al.
International Journal of Cardiology
|
February 24, 2021
ApoA-I mimetics improve aortic stenosis-associated left-ventricular diastolic dysfunction but fail to benefit rabbit models with normal aortic valves
Simon Kraler, Florian A Wenzl, Alexander Akhmedov, et al.
European Heart Journal
|
October 25, 2022
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease
Alexander Akhmedov, Tatsuya Sawamura, Chu-Huang Chen, et al.
European Heart Journal
|
November 7, 2020
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease
Alexander Akhmedov, Tatsuya Sawamura, Chu-Huang Chen, et al.
Frontiers in Cardiovascular Medicine
|
October 21, 2021
Inflammation in Metabolic Cardiomyopathy
Florian A Wenzl, Samuele Ambrosini, Shafeeq A Mohammed, et al.
Cardiovascular Research
|
March 8, 2024
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits
Alberto Preda, Fabrizio Montecucco, Federico Carbone, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 2, 2023
Network-Guided Multiomic Mapping of Aortic Valve Calcification
Mark C Blaser, Simon Kraler, Thomas F Lüscher, et al.
Journal of Cardiovascular Pharmacology
|
January 23, 2025
Colchicine in Coronary Artery Disease: Where Do We Stand?
Aldo Bonaventura, Nicola Potere, Luca Liberale, et al.
Frontiers in Cardiovascular Medicine
|
August 9, 2023
Editorial: Implications of lipids and modified lipoproteins in atherogenesis: from mechanisms towards novel diagnostic and therapeutic targets
Simon Kraler, Tatsuya Sawamura, Grace Yen-Shin Harn, et al.
European Heart Journal
|
December 1, 2021
Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy
Simon Kraler, Mark C Blaser, Elena Aikawa, et al.
Current Atherosclerosis Reports
|
March 22, 2025
Inflammation-Driven Plaque Erosion in Atherosclerosis: A Focus on Complement System Pathways
Davide Ramoni, Federico Carbone, Simon Kraler, et al.
International Journal of Cardiology
|
February 24, 2021
ApoA-I mimetics improve aortic stenosis-associated left-ventricular diastolic dysfunction but fail to benefit rabbit models with normal aortic valves
Simon Kraler, Florian A Wenzl, Alexander Akhmedov, et al.
European Heart Journal
|
October 25, 2022
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease
Alexander Akhmedov, Tatsuya Sawamura, Chu-Huang Chen, et al.
European Heart Journal
|
November 7, 2020
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease
Alexander Akhmedov, Tatsuya Sawamura, Chu-Huang Chen, et al.
Frontiers in Cardiovascular Medicine
|
October 21, 2021
Inflammation in Metabolic Cardiomyopathy
Florian A Wenzl, Samuele Ambrosini, Shafeeq A Mohammed, et al.
Cardiovascular Research
|
March 8, 2024
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits
Alberto Preda, Fabrizio Montecucco, Federico Carbone, et al.
Page
of 6